Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Intangibles (2016 - 2025)

Historic Intangibles for Lexaria Bioscience (LEXX) over the last 11 years, with Q4 2025 value amounting to $308060.0.

  • Lexaria Bioscience's Intangibles fell 3904.3% to $308060.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $308060.0, marking a year-over-year decrease of 3904.3%. This contributed to the annual value of $75106.0 for FY2025, which is 8546.36% down from last year.
  • Latest data reveals that Lexaria Bioscience reported Intangibles of $308060.0 as of Q4 2025, which was down 3904.3% from $75106.0 recorded in Q3 2025.
  • Over the past 5 years, Lexaria Bioscience's Intangibles peaked at $519253.0 during Q1 2024, and registered a low of $33778.0 during Q1 2023.
  • For the 5-year period, Lexaria Bioscience's Intangibles averaged around $277028.0, with its median value being $303554.5 (2021).
  • As far as peak fluctuations go, Lexaria Bioscience's Intangibles surged by 143725.21% in 2024, and later plummeted by 9209.4% in 2025.
  • Lexaria Bioscience's Intangibles (Quarter) stood at $378746.0 in 2021, then surged by 32.16% to $500549.0 in 2022, then decreased by 1.23% to $494377.0 in 2023, then grew by 2.22% to $505373.0 in 2024, then tumbled by 39.04% to $308060.0 in 2025.
  • Its last three reported values are $308060.0 in Q4 2025, $75106.0 for Q3 2025, and $60496.0 during Q2 2025.